Monitoring of drug safety

The article presents recommendations for doctors, pharmacists, developers and manufacturers on how to prepare and report to the regulatory ofthe Russian Federation individual case safety reports of adverse drug reactions,unefficiency or adverse drug interactions

Saved in:
Bibliographic Details
Main Authors: B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-06-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/307
Tags: Add Tag
No Tags, Be the first to tag this record!